Liberia Ebola vaccine trial "challenging" as cases tumble

A nurse holds a syringe containing an experimental Ebola vaccine during a media visit at the CHUV in LausanneBy Ben Hirschler DAVOS, Switzerland (Reuters) – A steep fall in Ebola cases in Liberia will make it hard to prove whether experimental vaccines work in a major clinical trial about to start in the country, the head of the U.S. National Institutes of Health (NIH) said on Saturday. The NIH might have to move some testing to neighbouring Sierra Leone, while regulators could end up approving Ebola shots based on efficacy data from animal tests backed by only limited human evidence, Francis Collins told Reuters. Liberia, once the epicentre of West Africa's deadly Ebola epidemic, has just five remaining confirmed cases of the disease, a senior health official has said.

Go to Source

British nurse makes full recovery from Ebola

A convoy carrying an Ebola patient arrive at the Royal Free Hospital in LondonA British nurse who had been critically ill with Ebola after working in Sierra Leone has been discharged from a London hospital after making a full recovery. Pauline Cafferkey was admitted to the Royal Free Hospital in north London on Dec. 30 after falling ill on her return from Sierra Leone, where she had been working for the charity Save the Children at a treatment centre outside the capital, Freetown.

Go to Source

1 12 13 14 15 16 59